chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 07-JUL-2014, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) by a physician, as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 25-JUL-2016, the patient was treated by the physician for the onset of a severe vesicular rash, which was diagnosed as herpes zoster, or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Loss of memory Violent headache Grand mal seizure Loss of appetite Loss of motor skills Blood clots Mouth drooping on one side Could not rule out stroke and possible mild heartattack
Varying oxygen levels; Fatigue; Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of OXYGEN SATURATION ABNORMAL (Varying oxygen levels), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Arm soreness) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced OXYGEN SATURATION ABNORMAL (Varying oxygen levels), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Arm soreness). On 13-Mar-2021, VACCINATION SITE PAIN (Arm soreness) had resolved. At the time of the report, OXYGEN SATURATION ABNORMAL (Varying oxygen levels) and FATIGUE (Fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Mar-2021, Oxygen saturation: abnormal (abnormal) abnormal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included blood pressure medication.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Event outcomes for varying oxygen levels, fatigue and arm soreness was updated from unknown to recovered/resolved.
Pain in the left armpit, with swollen glands, oral temperature of 38 degrees Celsius for 24 hours, general decline in evaluation.
his legs were weak; his arms felt like they were floating; seemed to move like he was drunk and uncoordinated; seemed to move like he was drunk and uncoordinated; got his second dose of the covid vaccine 2 weeks after his first dose; It is like a spinal cord myelitis; numbness in his hands and feet; This is a spontaneous report from a contactable consumer. This consumer (parent) reported for a 46-year-old male patient (reporter's son) that: A 46-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Lot Number: Unknown), via an unspecified route of administration as dose 2, single on 13Oct2021 (at the age of 46-year-old) for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccina included patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Lot Number: Unknown), via an unspecified route of administration as dose 1, single on unspecified date in Sep2021 for covid-19 immunisation and experienced sore arm. Patient got his second dose of the Covid vaccine (on 13Oct2021) 2 weeks after his first dose (inappropriate schedule of product administration). He had nothing but a sore arm after the first dose but within 8 hours after the second shot he began to experience numbness in his hands and feet on unspecified date in Oct2021 and the next day his legs were weak, and his arms felt like they were floating on 14Oct2021. Patient had to work very hard when walk to keep from falling he seemed to move like he was drunk and uncoordinated on 14Oct2021. This is the second day after his shot and his condition was unchanged. Has anyone reported any reactions similar to this. It was like a spinal cord myletitus on unspecified date in Oct2021. If he was no better by tomorrow 48 hours after the shot, we will get medical attention. Reporter's hope that others have had a reaction like this and that it was just a temporary condition. At the time of this report, the outcome of events was not recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Information has been received from a published article, title as stated above. This literature case was initially reported on 29-MAR-2010. This article concerned 32 patient's (8 male and 24 female) aged between one to 57 years (mean age of patients was 29 years). The patients received a RECOMBIVAX HB, manufacturer, batch number, route and site not reported, on unreported dates. This report concerns patient # 26 of 32, a 15 year old female. On an unreported date between 1982 and 2009, one to fifteen days post vaccination, the patient experienced uveitis (mean time to onset of three days). The uveitis was reported to occur after the first vaccination in 15 patients, after the second vaccination in three patients and after the third vaccination in three patients. The duration of the uveitis was not reported for nine patients. One patient had recurrent uveitis after the first and second doses of vaccine. One patient had recurrent uveitis after both the second and third doses. Patient outcome had not been reported. A 15 year old female on an unspecified date was vaccinated with a dose of RECOMBIVAX HB (lot number, route and site not reported). There was no concomitant medication. On an unspecified date after vaccination, the patient developed uveitis. At the time of the report, the patient's outcome was not reported. The authors stated the RECOMBIVAX HB may have a possible association with the development of uveitis in some patients. Immune complex deposition and adjuvant effects are potential pathogenic mechanisms. Uveitis was considered to be an other important medical event. Other business partner numbers include E2010-02312. Additional information has been requested. The article also discussed the experience of an additional 31 patients while on therapy with RECOMBIVAX HB (WAES #1004USA01716, WAES # 1004USA02327 to WAES # 1004USA02350, WAES # 1004USA02352 to WAES # 1004USA02357). A copy of the published article is attached as further documentation of the patient's experience.
This report is for a vaccine error --not an adverse event. The patient received a second dose Pfizer Covid-19 vaccine on 6/7/21 instead of second dose Moderna Covid-19 vaccine on 6/7/21. The patient received their first dose as Moderna on 5/10/21 and therefore should have received Moderna as their second dose as well.  Since we were doing both second dose clinics the same day this contributed to the error. The patient has been contacted and is not experiencing any adverse effects--fewer side effects than their Moderna vaccine dose. We let the patient know what happened and all steps we are taking to prevent this from happening in the future.
I had pancreatitis. I had two days before going to the ER my abdomen blew up like I was a starved child. I was in so much pain I could not breathe well.
1 1/2 inch by 1 1/2 inch red swollen and tender area left arm.
I stopped feeling present for many things, I don't seem to smell what is here, it's difficult thinking sometimes, and my mobility is off.  I feel like I'm walking with someone else's legs, and I feel weighted down.  Many different strange neurological symptoms overall.
Pt vaccinated with Fluzone developed lt Bell's palsy day after immunization & lasted  - 30D.
Fever 102 shakes chills abdominal pain sore throat, headache started at 10 pm on 4/6/09.
made my arm sore for days; I never felt good..; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm and feeling unwell. On an unknown date, the outcome of the pain in arm was recovered/resolved and the outcome of the feeling unwell was unknown.   It was unknown if the reporter considered the pain in arm and feeling unwell to be related to Shingles vaccine.  Additional case was reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient received a updated Shingle shot and had arm sore for days and never felt good and had receive another in 30 days, but it was better then shingles. The follow up would not be possible as no contact details were available.
redness appearing several days after the injection.  No pain, no iching, not raised.  Approx a 3 inch circle around the site of the injection.
Dizziness, NauseaVomiting, injextion sits R arm tingling radiating down are Narrative:  pt c/0 of pain in arm radiating 2' from inj site- no reddens noted ]reported similar reactions and Sx AFTER RECIEVEING 1 DOSE BUT WAS HOURS AFTER VACCINTION WAS GIVEN ta es had similar reaction of initial doses and that dizziness resolved on it own
Second dose....Low grade temperature, chills, fatigue, headache, runny nose, coughing, nausea.   Second day,  Red rash and warm at injection site, slightly itchy
After the first GARDASIL injection patient became very tired, severe headaches and abdominal pain. After second dose seizures began. After third dose seizures more frequently.
Vaccine received 3/13/15. Sore on 3/13/15. On morning of 3/14/15 was red and swollen. Continued to spread daily - pain intensifying as swelling increases. On 3/18/15 has red roundish swollen area 3x4" and painful.
painful, reddened hard et warm to touch, chills, aches, took Duracef for 7 days d/t cellulitis rt arm;
After the individual received his vaccine he went to the medical monitoring area with two additional members of his party.  At approximately 1412 the individuals friends alerted me that he needs help. I walked approximately 40 feet to find a 33 year old male patient that was unconscious and seizing.  The seizure lasted about 20-30 seconds with the patient waking up confused. I instructed someone from my team to call 911 and request an  ambulance.  Another team member and myself assisted the patient to a wheelchair and moved him to our treatment area approximately 50 feet away.  The patient was somewhat confused, hot & sweaty and fatigued.  I took a basic set of vital signs and got: BP 90/70 Pulse 56 Respirations 22 LOC x 4 No CBG  The ambulance arrived within 10 minuets and another round of vitals were taken.  The patients blood pressure and pulse were still low.  A CBG of 120 was achieved.  The patient was still hot / sweaty and fatigued.  The patient lied down on a cot and soon started feeling better.  He stopped sweating and his BP / Pulse started rising to within normal limits.  The two paramedics on site conducted a 12 lead ECG and didn't notice any amoralities.  Due to this incident being the first of its kind for the patient and without being a able to find a definitive known cause it was recommended that the patient be transported to the local hospital for further evaluation.  The patient declined and stated that he would have his friends take him if he starting feeling really bad.   It was strongly advised that he be transported via medics to the hospital but in the end the patient refused.
Pt with ESRD, tested asymptomatically COVID positive.  Was admitted due to acute anemia with a hemoglobin of 6.2 and nausea and vomting.
Case number PHEH2012US019089 is an initial spontaneous report received from a pharmacist on 20 Sep 2012 with the follow-up received on 19 Nov 2012: This report refers to an 18-years-old adult male patient.  He was vaccinated with MENVEO (batch number: X11032 (liquid) and A11032 (powder)) at dose of 0.5 ml subcutaneously on 19 Sep 2012. No adverse event was reported following this administration error. Follow-up received on 19 Nov 2012: Updated patient age, batch numbers and vaccine dose.
Site: Pain at Injection Site-Mild, Additional Details: PATIENT IS GIVEN EMPTY SYRINGE BEFORE SHE WAS GIVEN 0.3 ML OF PFIZER COVID 19 VACCINE. WHEN THE INCIDENT TOOK PLACE, I INFORMED HER THAT THE SYRINGE WAS EMPTY AND I HAD TO RE-STICK HER AGAIN WITH VACCINE. MOM CALLED AN HOUR LATER AND WANTED A REPORT DONE.
Night of vaccine: nausea, silver dollar size welt on arm, swollen/painful/itchy site of injection, trouble raising arm, red dot in middle of welt.
cold symptoms; runny nose; congestion in sinuses; scratchy throat; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold symptoms), RHINORRHOEA (runny nose), SINUS CONGESTION (congestion in sinuses) and THROAT IRRITATION (scratchy throat) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (cold symptoms), RHINORRHOEA (runny nose), SINUS CONGESTION (congestion in sinuses) and THROAT IRRITATION (scratchy throat). At the time of the report, NASOPHARYNGITIS (cold symptoms), RHINORRHOEA (runny nose), SINUS CONGESTION (congestion in sinuses) and THROAT IRRITATION (scratchy throat) outcome was unknown.
Father states child developed high fever, swollen, pain, child was taken to hospital. Was placed on Keflex 300mg-according to pediatrician was probable allergic reaction to DTaP. Discharge diagnosis/assessment: pt has decreased redness and swelling to his left arm. He has no fever. He is eating and drinking well. He has good movement to his L arm. He is able take his medicine.
Immediate soreness in arm, that did not go away after 2 weeks. Arm still sore and tingly, plus loss of range of motion. I believe the shot was given too high, near my shoulder bone. I saw my PCP today. He recommended heat and ibuprofen, and if it doesn't resolve by the weekend, we may have to do a bone scan.
not feeling well; heart palpitations; touble breathing; coughing all night; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not feeling well), PALPITATIONS (heart palpitations), COUGH (coughing all night) and DYSPNOEA (touble breathing) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2021, the patient experienced COUGH (coughing all night). On an unknown date, the patient experienced MALAISE (not feeling well), PALPITATIONS (heart palpitations) and DYSPNOEA (touble breathing). At the time of the report, MALAISE (not feeling well), PALPITATIONS (heart palpitations), COUGH (coughing all night) and DYSPNOEA (touble breathing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication provided by the reporter.  No treatment information reported by the reporter.
More vivid dreams/the dreams are so surreal; memory is sharper; This spontaneous case was reported by a consumer and describes the occurrence of ABNORMAL DREAMS (More vivid dreams/the dreams are so surreal) and THERAPEUTIC RESPONSE UNEXPECTED (memory is sharper) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABNORMAL DREAMS (More vivid dreams/the dreams are so surreal) and THERAPEUTIC RESPONSE UNEXPECTED (memory is sharper). At the time of the report, ABNORMAL DREAMS (More vivid dreams/the dreams are so surreal) and THERAPEUTIC RESPONSE UNEXPECTED (memory is sharper) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
extensive diffuse hair loss;large accumulation of hair in drain when showering;heavy loss approx 1-2yr;onset approx 3wk p/initial dose of vax; cont until present;tx p/ medical consult in 1994
10 year old male with chicken pox after vaccination with Varicella at age 20 months
Sore arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain in extremity (1st dose received on an unknown date, refer case US2021229149).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were reported as follows: The case was reported by the patient's wife. The age at vaccination was not reported. The reporter asked questions regarding Shingrix because she was thinking about getting it. The reporter stated her husband had Shingrix in the past and he only had a sore arm.  Limited information provided.
Sporadic rash. Shows on hands or arm,  It come for a couple of days then goes away, then comes back, usually on hands or arm. It is a burning itch. Feels warm to the touch. Tender to the touch.
Began with abdominal cramping and bleeding.  Completed miscarriage on Dec. 2nd, 2009.  Was in contact with doctor by phone.
Sore arm on day one then day 3 fever chills and aches muscle aches and just for the night day 4 okay
Patient started complaining of not being able to take a full inhale on evening of July 4th. Temperature was normal 97.7. Scheduled televisit with family practice and subsequent bloodwork . Pulse oximetry came back normal at 99% and heart rate  at 54 bpm. Normal bloodwork as well. Patient still has some labored difficulty taking full inhale but seems to be improving.
Migraine headache, nausea, muscle aches, weakness, fatigue, malaise.
Received MCV4 and seasonal TIV 9-16-09. Mom reported incident 10-15-09. Approximately 2 hours after receiving vaccines mom found him with with a blank look on face. 1/2 hour later felt "fuzzy", "dizzy" and hot, laid down on floor and could not move. Answered questions slowly with effort with mono syllables, PEARL. Mom took to ER, waited 2 hours without being seen and left in normal condition without further problem.
Child was in care of sibling, started shaking, arms turned purple.  Taken to ER and had 103 temp at the time. RPAC at ER consulted with special care physician and they determined it most likely was a seizure secondary to the MMR received 4/19/16.
PATIENT RECIEVED BOOSTER DOSE 2 MONTHS 2 EARLY AND IS NOT CLEARY INDICATED TO HAVE RECIEVED THE VACCINE AS DOES NOT MEET IMMUNOCOMPROMISED STATUS. WAS GIVEN VACCINE EARLY DUE TO ERROR THAT LED TO VACCINE NOT BEING DOCUMENTED PROPERLY.  PATIENT DID NOT EXPIERENCE ANY ADVERSE EFFECTS FROM THE EARLY BOOSTER.
Vaccines were given on 10/7/03 pm child developed fever next day and increased sleepiness. Mother called PMD's office at night of 10/8/03 and was given fever monitoring, testing instructions. Next time parent called on 10/12/03. Mother was informing us that pt was not moving a lot and had weakness of his L arm. Pt was taken to hospital ER and diagnosed with L hemiparesis. MRI of the head revealed R middle cerebral arthey ischemic stroke. He was admitted to the hospital inpatient floor. Extensive blood work up was done including coagulation studies, protein C, S, factor V Leida was negative. Etiology of this event is unclear. Child was started on anticoagulants during hospital stay. Currently is on no medications. The hospital records received on 3/23/04 states stroke.
Approximately 10 minutes after vax, developed red 3cm x 2cm area around the injection site with a couple of ? lesions.
Swollen painful lymph nodes left armpit; Swollen painful lymph nodes left armpit; This is a spontaneous report from a non-contactable nurse reporting for herself. A 41-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Jan2021 08:00 in left arm at single dose for COVID-19 immunization. Medical history included sulfa allergy from an unknown date and unknown if ongoing. Concomitant medication included buspirone hydrochloride (BUSPAR), lamotrigine (SUBVENITE) and quetiapine fumarate (SEROQUEL). The patient previously took amoxicillin and experienced allergies and received first dose of BNT162B2. The patient experienced swollen painful lymph nodes left armpit on an unspecified date. The outcome of the events was unknown. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The events was considered non serious as it did not result in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect.  No follow-up attempts are possible. No further information is expected.
Itchiness at vaccine site; Redness at vaccine site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness at vaccine site) and VACCINATION SITE ERYTHEMA (Redness at vaccine site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness at vaccine site) and VACCINATION SITE ERYTHEMA (Redness at vaccine site). At the time of the report, VACCINATION SITE PRURITUS (Itchiness at vaccine site) and VACCINATION SITE ERYTHEMA (Redness at vaccine site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.  Treatment information was not provided.